Treatment of Pterygium with Adjunctive Therapies

Surgical Management and Complications

• Mitomycin C is typically used at a concentration of 0.02% (0.2 mg/ml) for a brief period (e.g., 15 seconds) to prevent recurrence in patients undergoing pterygium surgery 1
• Diplopia can occur due to damage to the medial rectus or scarring in patients who have undergone pterygium surgery, with the American Academy of Ophthalmology recommending careful surgical technique to minimize this risk 2
• Strabismus, including exotropia from medial rectus damage or esotropic restrictive strabismus from scarring, is a potential complication of pterygium surgery, according to the American Academy of Ophthalmology 2
• Ocular motility problems from florid scarring associated with recurrence can occur in patients who have undergone pterygium surgery, highlighting the importance of regular postoperative follow-up, as recommended by the American Academy of Ophthalmology 2
• The use of topical rather than retrobulbar anesthesia can reduce the risk of postoperative diplopia in patients undergoing pterygium surgery, as suggested by the American Academy of Ophthalmology 2